OVERVIEW

Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Annual Meeting 2023 is organized by Practical Recommendations in Immuno and Molecular Oncology (PRIMO) and will be held from Feb 22 - 25, 2023 at Hilton Hawaiian Village Waikiki Beach Resort, Honolulu, Hawaii, United States of America.

Learning Objectives:
Practical considerations of applying biomarkers and targeted therapy Integration of immunotherapy, with a focus on novel management, approaches Patient selection, as well as timing and sequencing of therapy Dealing with important trends, such as big data and defining value in cancer care

Educational Objectives:
After completing this activity, the participant should be better able to:
• Describe the rationale for mechanisms of action for molecular targeted and immunologic therapies used to treat cancer today;
• Summarize recent advances in the targeted and immunologic treatment of hematologic malignancies and solid tumors;
• Identify patients who are appropriate candidates for targeted and immunologic therapies;
• Implement strategies from a healthcare team approach to reduce treatment-related toxicities, and optimize patient outcomes;
• Discuss promising targeted and immunologic approaches being tested in late-stage clinical trials.

KEY DATES

Event Start Date
22 Feb, 2023
Event Start Date
Event End Date
25 Feb, 2023
Event End Date
Credits
  • 12.5 AMA PRA Category 1 Credits™
  • 12.5 MOC
  • 12.5 IPCE
  • 12.5 Contact Hours
  • TARGET AUDIENCE

    PhysicianNursingPharmacistPhysician AssistantAllied Health ProfessionalsFellowsOncologistsResidents

    SPECIALITIES

    Oncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationHilton Hawaiian Village Waikiki Beach Resort
    2005 Kalia Rd

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235